Entropion Treatment Market Share

  • Report ID: 3777
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Entropion Treatment Market - Regional Analysis

North American Market Insights

The North America industry is anticipated to hold largest revenue share by 2035. The growth of the market can be attributed majorly to the rising cases of entropion in older adults and higher number of people suffering with dry eye issues. According to the American Academy of Ophthalmology, the prevalence of entropion increases with the age, it increased by around 1% for patients aged 60 to 69, nearly 2% for those aged 70 to 79, and around 8% for those above the age of 80. Moreover, in America, between 16 and 49 million people have dry eyes, which accounts for 15% of the population.

APAC Market Insights

The Asia Pacific entropion treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market in the region is credited to large geriatric population in countries that increase the chances of entropion patients in the region, such as India and China. According to the data by the World Bank, the population above 65 years of age in India crossed 90,719,952 in 2020, while, it crossed 167,808,567 in China. 

Entropion-Treatment-Market-share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of entropion treatment is assessed at USD 538.67 million.

The global entropion treatment market size was valued at over USD 507.6 million in 2025 and is expected to expand at a CAGR of around 6.8%, surpassing USD 980.02 million revenue by 2035.

North America entropion treatment market is anticipated to command a leading revenue share, fueled by the escalating incidence of age-related entropion and widespread dry eye conditions across the elderly population.

Key players in the market include Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and Alembic Limited.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos